Amphastar Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of AMPH for the last quarter is 191.21 M USD, and it's 4.84% higher compared to the previous quarter. The net income of Q3 24 is 40.43 M USD.